These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38311473)

  • 41. Suicidal and self-harm behaviour associated with adolescent attention deficit hyperactivity disorder-a study in the Northern Finland Birth Cohort 1986.
    Hurtig T; Taanila A; Moilanen I; Nordström T; Ebeling H
    Nord J Psychiatry; 2012 Oct; 66(5):320-8. PubMed ID: 22242914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attention-deficit/hyperactivity disorder persistence from childhood into young adult age: a 10-year longitudinal study.
    Skogli EW; Orm S; Fossum IN; Andersen PN; Øie MG
    Cogn Neuropsychiatry; 2022 Nov; 27(6):447-457. PubMed ID: 36102071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of equine-assisted activities on attention and quality of life in children with cerebral palsy in a randomized trial: examining the comorbidity with attention-deficit/hyperactivity disorder.
    Ahn B; Joung YS; Kwon JY; Lee DI; Oh S; Kim BU; Cha JY; Kim JH; Lee JY; Shin HY; Seo YS
    BMC Pediatr; 2021 Mar; 21(1):135. PubMed ID: 33740922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attention deficit hyperactivity disorder and personality characteristics in older adults in the general Dutch population.
    Michielsen M; Comijs HC; Semeijn EJ; Beekman AT; Deeg DJ; Kooij JJ
    Am J Geriatr Psychiatry; 2014 Dec; 22(12):1623-32. PubMed ID: 24656507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trait emotional intelligence in a sample of Egyptian children with attention deficit hyperactivity disorder.
    Abo Elella E; Hassan GAM; Sabry W; Hendawy H; Shorub E; Zyada F; Medany O
    Child Adolesc Ment Health; 2017 Nov; 22(4):216-223. PubMed ID: 32680413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Co-morbidity of bipolar disorder in children and adolescents with attention deficit/hyperactivity disorder (ADHD) in an outpatient Turkish sample.
    Lus G; Mukaddes NM
    World J Biol Psychiatry; 2009; 10(4 Pt 2):488-94. PubMed ID: 19401947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical features and subjective/physiological responses to emotional stimuli in the presence of emotion dysregulation in attention-deficit hyperactivity disorder.
    Taskiran C; Karaismailoglu S; Cak Esen HT; Tuzun Z; Erdem A; Balkanci ZD; Dolgun AB; Cengel Kultur SE
    J Clin Exp Neuropsychol; 2018 May; 40(4):389-404. PubMed ID: 28721740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors influencing severity of attention deficit hyperactivity disorder in a sample of preparatory school students in Cairo.
    Ramy H; El Sheikh M; Sultan M; Bassim R; Eid M; Ali R; El Missiry M
    Clin Child Psychol Psychiatry; 2018 Oct; 23(4):542-555. PubMed ID: 29451009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parent SNAP-IV rating of attention-deficit/hyperactivity disorder: accuracy in a clinical sample of ADHD, validity, and reliability in a Brazilian sample.
    Costa DS; de Paula JJ; Malloy-Diniz LF; Romano-Silva MA; Miranda DM
    J Pediatr (Rio J); 2019; 95(6):736-743. PubMed ID: 30236592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attention deficit and hyperactivity in social anxiety disorder: relationship with trauma history and impulsivity.
    Koyuncu A; Çelebi F; Ertekin E; Kök BE; Tükel R
    Atten Defic Hyperact Disord; 2016 Jun; 8(2):95-100. PubMed ID: 26797941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Reliability and Validity of the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version, DSM-5 November 2016-Turkish Adaptation (K-SADS-PL-DSM-5-T)].
    Ünal F; Öktem F; Çetin Çuhadaroğlu F; Çengel Kültür SE; Akdemir D; Foto Özdemir D; Çak HT; Ünal D; Tıraş K; Aslan C; Kalaycı BM; Aydos BS; Kütük F; Taşyürek E; Karaokur R; Karabucak B; Karakök B; Karaer Y; Artık A
    Turk Psikiyatri Derg; 2019; 30(1):42-50. PubMed ID: 31170306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK.
    Matza LS; Secnik K; Mannix S; Sallee FR
    Pharmacoeconomics; 2005; 23(8):777-90. PubMed ID: 16097840
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comorbidity and Factors Affecting Treatment Non-Persistence in ADHD.
    Park J; Kim B
    J Atten Disord; 2020 Jul; 24(9):1276-1284. PubMed ID: 26006168
    [No Abstract]   [Full Text] [Related]  

  • 54. Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: prevalence and clinical correlates.
    Tamam L; Karakus G; Ozpoyraz N
    Eur Arch Psychiatry Clin Neurosci; 2008 Oct; 258(7):385-93. PubMed ID: 18437277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension.
    Weiss MD; Cutler AJ; Kollins SH; Donnelly GAE
    J Child Adolesc Psychopharmacol; 2021 Nov; 31(9):610-622. PubMed ID: 34637343
    [No Abstract]   [Full Text] [Related]  

  • 56. Dimensional profiling of psychopathology in children and adolescents based on the K-SADS-PL and an analysis of the construct validity of two ADHD symptom dimensions.
    Hagstrøm J; Nielsen T; Sørensen ME; Aagaard K; Arendt Rasmussen M; Rosenberg JB; Mohammadzadeh P; Sevelsted A; Hernández-Lorca M; Fagerlund B; Rydkjær J; Pagsberg AK; Kaufman J; Ebdrup BH; Bilenberg N; Jepsen JRM
    Nord J Psychiatry; 2024 Jan; 78(1):71-78. PubMed ID: 37755235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of severe ADHD: an epidemiological study in the Italian regions of Tuscany and Latium.
    Donfrancesco R; Marano A; Calderoni D; Mugnaini D; Thomas F; Di Trani M; Innocenzi M; Vitiello B
    Epidemiol Psychiatr Sci; 2015 Dec; 24(6):525-33. PubMed ID: 25221947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of comorbidity and psychological outcomes in children and adolescents with attention-deficit/hyperactivity disorder.
    Huh Y; Choi I; Song M; Kim S; Hong SD; Joung Y
    Psychiatry Investig; 2011 Jun; 8(2):95-101. PubMed ID: 21852984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mood and Proneness to Boredom Are Associated with Poorer Continuous Performance Test Results, Which May Improve with Methylphenidate Treatment, in Attention-Deficit/Hyperactivity Disorder.
    Golubchik P; Schoen G; Weizman A
    J Child Adolesc Psychopharmacol; 2021 May; 31(4):310-314. PubMed ID: 33956509
    [No Abstract]   [Full Text] [Related]  

  • 60. Methylphenidate treatment for attention-deficit/hyperactivity disorder in children and adolescents with velocardiofacial syndrome: an open-label study.
    Gothelf D; Gruber R; Presburger G; Dotan I; Brand-Gothelf A; Burg M; Inbar D; Steinberg T; Frisch A; Apter A; Weizman A
    J Clin Psychiatry; 2003 Oct; 64(10):1163-9. PubMed ID: 14658963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.